Global immunohaematology market to grow by $1.06b until 2028

Advanced molecular techniques are expected to fuel its growth.

The global market for immunohaematology is projected to grow by $1.06b until 2028 at an estimated compound annual growth rate (CAGR) of 7.35%.

A report by Technavio revealed that is experiencing notable growth due to a rising demand for advanced diagnostic tools and technologies, with blood products and associated technologies as key areas of focus.

“Forms of assays such as ELISA, Western blot, and flow cytometry are commonly used in immunohematology. These techniques aid in the detection and identification of various antigens and antibodies,” The report said.

Moreover, advanced molecular techniques are anticipated to fuel growth, with the market driven by a call for personalised medicine and the development of new therapeutic approaches.

Meanwhile, molecular immunohaematology serves as a trend due to an expected paradigm shift towards the technique in the market.

According to the report, molecular analysis plays an important role in detecting antigen molecular and genetic structures.

“This method is now a standard practice before unrelated donor blood transfusions due to cross-matching requirements,” It added.